Xenetic Biosciences, Inc.
XBIO
$4.11
-$0.17-3.97%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 6.47M | 7.35M | 7.88M | 4.12M | 4.78M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 154.30K | 219.80K | 113.30K | 646.40K | 223.90K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 28.00K | 28.00K | 53.00K | 300.00K | 350.00K |
| Total Current Assets | 6.65M | 7.60M | 8.05M | 5.07M | 5.35M |
|
|
|||||
| Total Current Assets | 6.65M | 7.60M | 8.05M | 5.07M | 5.35M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 313.90K | 313.90K | 313.90K | -- | -- |
| Total Assets | 6.97M | 7.91M | 8.36M | 5.07M | 5.35M |
|
|
|||||
| Total Accounts Payable | 322.50K | 558.80K | 258.10K | 508.30K | 346.80K |
| Total Accrued Expenses | 441.40K | 399.40K | 703.30K | 463.50K | 526.60K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | 6.70K | -- | -- |
| Total Finance Division Other Current Liabilities | 131.00K | -- | -- | 140.00K | 30.00K |
| Total Other Current Liabilities | 131.00K | -- | -- | 140.00K | 30.00K |
| Total Current Liabilities | 895.00K | 958.20K | 968.00K | 1.11M | 903.40K |
|
|
|||||
| Total Current Liabilities | 895.00K | 958.20K | 968.00K | 1.11M | 903.40K |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 895.00K | 958.20K | 968.00K | 1.11M | 903.40K |
|
|
|||||
| Common Stock & APIC | 212.36M | 212.31M | 212.30M | 208.28M | 208.26M |
| Retained Earnings | -201.26M | -200.33M | -199.88M | -199.30M | -198.79M |
| Treasury Stock & Other | -5.03M | -5.03M | -5.03M | -5.03M | -5.03M |
| Total Common Equity | 6.07M | 6.95M | 7.39M | 3.95M | 4.45M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | 1.50K | 1.50K | 1.80K | 1.80K |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | 1.50K | 1.50K | 1.80K | 1.80K |
|
|
|||||
| Total Common Equity | 6.07M | 6.95M | 7.39M | 3.95M | 4.45M |
| Total Preferred Equity | -- | 1.50K | 1.50K | 1.80K | 1.80K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 6.07M | 6.95M | 7.40M | 3.96M | 4.45M |
|
|
|||||